LI J,CHEN X,HUANG J H,et al.Identification of critical antibody-binding sites in the HIV-1gp41six-helix bundle core as potential targets for HIV-1fusion inhibitors[J].Immunobiology,2009,214(1):51-60.
[2]
ZHOU G Y,WU D,SNYDER B,et al.Development of indole compounds as small molecule fusion inhibitors targeting HIV-1glycoprotein-41[J].J Med Chem,2011,54(20):7220-7231.
[3]
JIANG S B,TALA S R,LU H,et al.Design,synthesis,and biological activity of a novel series of2,5-disubstituted furans/pyrroles as HIV-1fusion inhibitors targeting gp41[J].Bioorg Med Chem Lett,2011,21(22):6895-6898.
[4]
HE X Y,ZOU P,QIU J Y,et al.Design,synthesis and biological evaluation of3-substituted2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1gp41inhibitors[J].Bioorg Med Chem,2011,19(22):6726-6734.
[5]
ZHANG Y T,CHENG Z J,FU W Z.QSAR study of carboxylic acid derivatives as HIV-1integrase inhibitors[J].Eur J Med Chem,2010,45(9):3970-3980.
[6]
ANDREWS K M,CRAMER R D.Toward general methodsof targeted library design:Topomer shape similarity searching with diverse structures as queries[J].J Med Chem,2000,43(9):1723-1740.
[7]
CRAMER R D,CRUZ P,STAHL G,et al.Virtual screening for r-groups,including predicted pIC50 contributions,within large structural databases,using topomer CoMFA[J].J Chem Inf Model,2008,48(11):2180-2195.
[8]
CRAMER R D.COMP226-Virtual screening for superior R-groups[J].Abstr Pap Am Chem Soc,2008,235:226.
[9]
TEIXEIRA C,BARBAULT F,REBEHMED J,et al.Molecular modeling studies of N-substituted pyrrole derivatives-potential HIV-1gp41inhibitors[J].Bioorg Med Chem,2008,16(6):3039-3048.
[10]
BASAK S C,NATARAJAN R,MILLS D,et al.Quantitative structure-activity relationship modeling of juvenile hormone mimetic compounds for Culex pipiens larvae,with a discussion of descriptor-thinning methods[J].J Chem Inf Model,2006,46(1):65-77.
[11]
TENENHAUS M,VINZI V E,CHATELIN Y M,et al.PLS path modeling[J].Computational Statistics&Data Analysis,2005,48(1):159-205.
[12]
AJALA A O,OKORO C O.CoMFA and CoMSIA studies on fluorinated hexahydropyrimidine derivatives[J].Bioorg Med Chem Lett,2011,21(24):7392-7398.
[13]
GOLBRAIKH A,TROPSHA A.Beware of q(2)![J].J Mol Graph Model,2002,20(4):269-276.
[14]
TAN J J,CONG X J,HU L M,et al.Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection[J].Drug Discov Today,2010,15(5/6):186-197.
[15]
PAN C G,LIU S W,JIANG S B.HIV-1gp41fusion intermediate:a target for HIV therapeutics[J].J Formos Med Assoc,2010,109(2):94-105.
